Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial.

Postgraduate medicine

Volumn 125, Issue 3, 2013, Pages 204-213

  Grabner, Michael ^a   Chu, James ^b   Raparla, Swetha ^b   Quimbo, Ralph ^b   Zhou, Steve ^b   Conoshenti, Joseph ^b  

^a HEALTHCORE INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLARGINE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LONG ACTING INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DRUG COST; ECONOMICS; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROPENSITY SCORE; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; DELIVERY OF HEALTH CARE; DIABETES MELLITUS, TYPE 2; DRUG COSTS; FEMALE; HEALTH CARE COSTS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN, LONG-ACTING; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROPENSITY SCORE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84882268201     PISSN: None     EISSN: 19419260     Source Type: None    
DOI: 10.3810/pgm.2013.05.2656     Document Type: Article

References (0)